Clinical Trial Infrastructure

Full-service early-phase CRO with dedicated psychedelic clinical trial teams, specialized set-and-setting units, and integrated capabilities from preclinical support through early clinical proof-of-concept.

Swedish full-service CRO with early-phase concentration, integrated site network, and in-house capabilities spanning project management, monitoring, biometrics, pharmacovigilance, and medical writing.

U.S. clinical site network and clinical sciences platform focused on CNS and early-phase development, with dedicated psychedelic research expertise and integrated patient recruitment operations.

UK-based specialist CNS and psychiatry-focused clinical research organization combining select CRO services, dedicated trial sites, participant recruitment, and psychedelic therapist training for complex mental-health studies.

Global CNS-focused full-service CRO operating Phase 1 research units and end-to-end trial services, with documented psychedelic and hallucinogenic clinical studies and controlled-substance trial infrastructure.

Clinical trial technology provider (now part of Clario branding) offering neuroscience-focused eCOA and endpoint-quality services for global CNS studies, including methodologies relevant to psychedelic-assisted therapy trials.

UK clinical research organization and site operator focused on complex CNS and psychedelic studies, with dedicated psychedelic testing suites and early-to-late phase delivery capabilities.

Physician-led New Zealand clinical research organization with early-phase specialization and multi-site operations; identified in partner disclosures as experienced in psychedelic studies.

Global full-service biotech-focused CRO supporting development across clinical phases, with publicly stated psychedelic trial collaborations and formal partnerships with experienced psychedelics research centers.

Not-for-profit psychedelic clinical research consortium offering shared site infrastructure, harmonized SOPs, benchmarking, centralized recruitment support, and patient registry workflows.

Global eClinical and endpoint-science provider offering psychedelic-focused trial methodology, protocol-to-endpoint support, and purpose-built data quality workflows for psychiatry and CNS programs.

Australian full-service CRO focused on early-phase clinical development in APAC, with confirmed role supporting a Phase IIb psilocybin-assisted psychotherapy trial and broad operational trial services.

Clinical trial patient recruitment and enrollment platform providing multilingual digital pre-screening, referral workflows, and real-time recruitment analytics for sponsors, CROs, and sites.

Global full-service CRO with a dedicated psychedelic center of excellence supporting psychiatry-focused psychedelic clinical development programs, including large multicountry studies.